HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Hyeh Ko Selected Research

Hydroa Vacciniforme

6/2021Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Hyeh Ko Research Topics

Disease

26Neoplasms (Cancer)
01/2020 - 12/2006
6Lymphoma (Lymphomas)
12/2018 - 01/2008
6Neoplasm Metastasis (Metastasis)
12/2016 - 11/2009
4B-Cell Lymphoma (Lymphoma, B Cell)
03/2017 - 01/2008
3Disease Progression
06/2021 - 11/2011
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2016 - 03/2007
3Carcinoma (Carcinomatosis)
05/2015 - 02/2006
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2009 - 01/2008
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2018 - 07/2015
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2017 - 01/2017
2Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 01/2014
2Residual Neoplasm
09/2016 - 01/2007
2Adenoid Cystic Carcinoma (Cylindroma)
09/2016 - 05/2012
2Squamous Cell Carcinoma of Head and Neck
01/2016 - 11/2009
2Pharyngeal Neoplasms
01/2016 - 09/2009
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
05/2013 - 02/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2012 - 10/2006
2Papillary Thyroid Microcarcinoma
06/2012 - 03/2012
1Genomic Instability
01/2022
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
06/2021
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2021
1Hydroa Vacciniforme
06/2021
1Inflammation (Inflammations)
03/2017
1Vascular Diseases (Vascular Disease)
03/2017
1Margins of Excision
12/2016
1Salivary Gland Neoplasms (Salivary Gland Cancer)
12/2016
1Hypopharyngeal Neoplasms
01/2016
1Lymphatic Metastasis
01/2016
1Mouth Neoplasms (Oral Cancer)
01/2016
1Tongue Neoplasms (Tongue Neoplasm)
01/2016
1Sarcoma (Soft Tissue Sarcoma)
05/2015
1Cholangiocarcinoma
05/2014
1Brain Neoplasms (Brain Tumor)
01/2014
1Glioblastoma (Glioblastoma Multiforme)
01/2014
1Pleomorphic Adenoma
07/2013
1Esophageal Squamous Cell Carcinoma
01/2012
1Neuroblastoma
08/2010
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
02/2010
1Heart Neoplasms
03/2009

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2008
3RNA (Ribonucleic Acid)IBA
01/2017 - 01/2014
3Anaplastic Lymphoma KinaseIBA
05/2015 - 02/2010
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2009 - 09/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2021 - 02/2009
2LigandsIBA
03/2017 - 01/2017
2Biological ProductsIBA
01/2016 - 07/2015
2Hematoxylin (Haematoxylon)IBA
05/2014 - 04/2014
2Eosine Yellowish-(YS) (Eosin)IBA
05/2014 - 04/2014
2Pharmaceutical PreparationsIBA
01/2014 - 06/2013
2ParaffinIBA
12/2012 - 12/2008
21-dodecylpyridoxal (PLD)IBA
06/2012 - 04/2010
2NF-kappa B (NF-kB)IBA
01/2012 - 01/2008
2Cyclin-Dependent Kinase Inhibitor p16IBA
02/2009 - 01/2008
1InterferonsIBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2018
1TNF Receptor-Associated Factor 3IBA
01/2018
1Nucleic AcidsIBA
05/2017
1Member 14 Tumor Necrosis Factor ReceptorsIBA
03/2017
1Glycoproteins (Glycoprotein)IBA
03/2017
1Lymphotoxin-alpha (Lymphotoxin)IBA
03/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2017
1FibrinIBA
03/2017
1Notch ReceptorsIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1Paclitaxel (Taxol)FDA LinkGeneric
01/2017
1Biological FactorsIBA
01/2016
1CrizotinibIBA
05/2015
1Keratins (Keratin)IBA
05/2014
1BrevicanIBA
01/2014
16- (4- (3- (methylsulfonyl)benzylamino)- 5- (trifluoromethyl)pyrimidin- 2- ylamino)- 3,4- dihydroquinolin- 2(1H)- oneIBA
01/2014
1N- methyl- N- (3- ((2- (2- oxo- 2,3- dihydro- 1H- indol- 5- ylamino)- 5- trifluoromethyl- pyrimidin- 4- ylamino)- methyl)- pyridin- 2- yl)- methanesulfonamideIBA
01/2014
1Nerve Growth Factor (NGF)IBA
01/2014
1trkA ReceptorIBA
01/2014
1AgarIBA
01/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2013
1CollagenIBA
07/2013
1VorinostatFDA Link
06/2013
1Antineoplastic Agents (Antineoplastics)IBA
01/2013
1Formaldehyde (Formol)FDA Link
12/2012
1Vascular Endothelial Growth FactorsIBA
06/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2012
1sodium-iodide symporter (sodium iodide symporter)IBA
03/2012
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
03/2012
1Biomarkers (Surrogate Marker)IBA
01/2012
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
08/2010
1MethyltransferasesIBA
02/2009
1Death-Associated Protein KinasesIBA
02/2009
1O-(6)-methylguanineIBA
02/2009
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2007

Therapy/Procedure

8Therapeutics
01/2020 - 02/2010
8Drug Therapy (Chemotherapy)
03/2017 - 01/2007
3Radiotherapy
12/2016 - 09/2009
3Neck Dissection (Radical Neck Dissection)
03/2012 - 02/2006
2Operative Surgical Procedures
09/2016 - 03/2009
1Conservative Treatment
06/2021
1Oral Surgery (Maxillofacial Surgery)
01/2016
1Pancreaticoduodenectomy
05/2014
1Thyroidectomy
03/2012